MicroRNA miR-451 downregulates the PI3K/AKT pathway through CAB39 in human glioma

International Journal of Oncology

Volumn 40, Issue 4, 2012, Pages 1105-1112

  Tian, Yuan ^a,b,c   Nan, Yang ^a,b,c   Han, Lei ^a,b,c   Zhang, Anling ^b,c   Wang, Guangxiu ^b,c   Jia, Zhifan ^b,c   Hao, Jianwei ^a,b,c   Pu, Peiyu ^b,c   Zhong, Yue ^a   Kang, Chunsheng ^a,b,c  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b Tianjin Neurological Institute   (China)

^c BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Calcium binding protein 39; Glioma; MicroRNA 451; Target gene

Indexed keywords

ADENYLATE KINASE; AKT1 PROTEIN; ANTINEOPLASTIC AGENT; CALCIUM BINDING PROTEIN; CALCIUM BINDING PROTEIN 39; CELL PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; MICRORNA; MICRORNA 451; OLIGONUCLEOTIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE LKB1; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GRADING; CANCER INHIBITION; CANCER SIZE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; GENE EXPRESSION REGULATION; GLIOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BRAIN NEOPLASMS; CALCIUM-BINDING PROTEINS; CELL LINE, TUMOR; DOWN-REGULATION; GLIOMA; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; TRANSFECTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84863392564     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.1306     Document Type: Article

References (40)

1. Furnari FB, Fenton T, Bachoo RM, et al: Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev 21: 2683-2710, 2007. (Pubitemid 350070717)
2. Van Meir EG, Hadjipanayis CG, Norden AD, Shu HK, Wen PY and Olson JJ: Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J Clin 60: 166-193, 2010.
3. Gal H, Pandi G, Kanner AA, et al: MIR-451 and imatinib mesylate inhibit tumor growth of glioblastoma stem cells. Biochem Biophys Res Commun 376: 86-90, 2008.
4. Zhang CZ, Zhang JX, Zhang AL, et al: MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma. Mol Cancer 9: 229, 2010.
5. Liu T, Tang H, Lang Y, Liu M and Li X: MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin. Cancer Lett 273: 233-242, 2009.
6. Moriyama T, Ohuchida K, Mizumoto K, et al: MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance. Mol Cancer Ther 8: 1067-1074, 2009.
7. Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R and Rajewsky N: Widespread changes in protein synthesis induced by microRNAs. Nature 455: 58-63, 2008.
8. Tay Y, Zhang J, Thomson AM, Lim B and Rigoutsos I: MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 455: 1124-1128, 2008.
9. Chi SW, Zang JB, Mele A and Darnell RB: Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature 460: 479-486, 2009.
10. He L and Hannon GJ: MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5: 522-531, 2004. (Pubitemid 38868508)
11. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A and Enright AJ: miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34: D140-D144, 2006.
12. Ambros V: The functions of animal microRNAs. Nature 431: 350-355, 2004.
13. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
14. Hwang HW and Mendell JT: MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer 94: 776-780, 2006.
15. Bandres E, Agirre X, Ramirez N, Zarate R and Garcia-Foncillas J: MicroRNAs as cancer players: potential clinical and biological effects. DNA Cell Biol 26: 273-282, 2007. (Pubitemid 46799176)
16. Mahlamaki EH, Barlund M, Tanner M, et al: Frequent amplification of 8q24, 11q, 17q, and 20q-specific genes in pancreatic cancer. Genes Chromosomes Cancer 35: 353-358, 2002. (Pubitemid 35246993)
17. Varis A, Wolf M, Monni O, et al: Targets of gene amplification and overexpression at 17q in gastric cancer. Cancer Res 62: 2625-2629, 2002.
18. Nan Y, Han L, Zhang A, et al: MiRNA-451 plays a role as tumor suppressor in human glioma cells. Brain Res 1359: 14-21, 2010.
19. von Mering C, Huynen M, Jaeggi D, Schmidt S, Bork P and Snel B: STRING: a database of predicted functional associations between proteins. Nucleic Acids Res 31: 258-261, 2003. (Pubitemid 36150379)
20. Kanehisa M and Goto S: KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28: 27-30, 2000. (Pubitemid 30047706)
21. Griffiths-Jones S, Saini HK, van Dongen S and Enright AJ: miRBase: tools for microRNA genomics. Nucleic Acids Res 36: D154-D158, 2008. (Pubitemid 351149713)
22. Kruger J and Rehmsmeier M: RNAhybrid: microRNA target prediction easy, fast and flexible. Nucleic Acids Res 34: W451-W454, 2006. (Pubitemid 44529811)
23. Kang CS, Zhang ZY, Jia ZF, et al: Suppression of EGFR expression by antisense or small interference RNA inhibits U251 glioma cell growth in vitro and in vivo. Cancer Gene Ther 13: 530-538, 2006.
24. Zhang J, Han L, Zhang A, et al: AKT2 expression is associated with glioma malignant progression and required for cell survival and invasion. Oncol Rep 24: 65-72, 2010.
25. Wan HY, Guo LM, Liu T, Liu M, Li X and Tang H: Regulation of the transcription factor NF-kappaB1 by microRNA-9 in human gastric adenocarcinoma. Mol Cancer 9: 16, 2010.
26. Brazil DP, Park J and Hemmings BA: PKB binding proteins. Getting in on the Akt. Cell 111: 293-303, 2002. (Pubitemid 35341386)
27. Dufour G, Demers MJ, Gagne D, et al: Human intestinal epithelial cell survival and anoikis. Differentiation state-distinct regulation and roles of protein kinase B/Akt isoforms. J Biol Chem 279: 44113-44122, 2004. (Pubitemid 39403045)
28. Alessi DR, Sakamoto K and Bayascas JR: LKB1-dependent signaling pathways. Annu Rev Biochem 75: 137-163, 2006. (Pubitemid 44118029)
29. Boudeau J, Baas AF, Deak M, et al: MO25alpha/beta interact with STRADalpha/beta enhancing their ability to bind, activate and localize LKB1 in the cytoplasm. EMBO J 22: 5102-5114, 2003. (Pubitemid 37222030)
30. Milburn CC, Boudeau J, Deak M, Alessi DR and van Aalten DM: Crystal structure of MO25 alpha in complex with the C terminus of the pseudo kinase STE20-related adaptor. Nat Struct Mol Biol 11: 193-200, 2004. (Pubitemid 38146524)
31. Brajenovic M, Joberty G, Kuster B, Bouwmeester T and Drewes G: Comprehensive proteomic analysis of human Par protein complexes reveals an interconnected protein network. J Biol Chem 279: 12804-12811, 2004. (Pubitemid 38445853)
32. Baas AF, Boudeau J, Sapkota GP, et al: Activation of the tumour suppressor kinase LKB1 by the STE20-like pseudokinase STRAD. EMBO J 22: 3062-3072, 2003. (Pubitemid 36758626)
33. Hemminki A, Markie D, Tomlinson I, et al: A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 391: 184-187, 1998. (Pubitemid 28092478)
34. Jenne DE, Reimann H, Nezu J, et al: Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet 18: 38-43, 1998. (Pubitemid 28027876)
35. Hardie DG, Scott JW, Pan DA and Hudson ER: Management of cellular energy by the AMP-activated protein kinase system. FEBS Lett 546: 113-120, 2003. (Pubitemid 36782291)
36. Hawley SA, Boudeau J, Reid JL, et al: Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J Biol 2: 28, 2003.
37. Woods A, Johnstone SR, Dickerson K, et al: LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr Biol 13: 2004-2008, 2003. (Pubitemid 37425212)
38. Vanhaesebroeck B, Leevers SJ, Ahmadi K, et al: Synthesis and function of 3-phosphorylated inositol lipids. Annu Rev Biochem 70: 535-602, 2001. (Pubitemid 32662219)
39. Cheng CK, Fan QW and Weiss WA: PI3K signaling in glioma-animal models and therapeutic challenges. Brain Pathol 19: 112-120, 2009.
40. Tao R, Gong J, Luo X, et al: AMPK exerts dual regulatory effects on the PI3K pathway. J Mol Signal 5: 1, 2010.